Jove
Visualize
Contact Us

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

2.4K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.4K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

726
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
726
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STEPS approach allows patient to participate in decision making.

American family physician·2011
Same author

Pharmacologic treatment of hyperlipidemia.

American family physician·2011
Same author

Chronic low back pain: evaluation and management.

American family physician·2009
Same author

Modifying a traditional course for the PharmD curriculum.

American journal of pharmaceutical education·2009
Same author

Choosing topical corticosteroids.

American family physician·2009
Same author

A partial solution to a big problem.

Archives of internal medicine·2007
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.

Allen R Last1, Jonathan D Ference2, Elizabeth Rollmann Menzel1

  • 1Medical College of Wisconsin Fox Valley Family Medicine Residency Program, Appleton, WI, USA.

American Family Physician
|January 14, 2017
PubMed
Summary
This summary is machine-generated.

Current guidelines recommend statin therapy for atherosclerotic cardiovascular disease (ASCVD) prevention based on patient risk, not just lipid levels. Statins are the primary lipid-lowering drug, with other options available for intolerance.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Lipid-lowering drugs, particularly statins, are recommended for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) events.
  • Current guidelines from major health organizations (ACC/AHA, NICE, USPSTF) emphasize risk-based statin initiation over treatment to specific lipid targets.
  • Evidence supporting statins for ASCVD prevention is robust.

Purpose of the Study:

  • To summarize current guidelines on lipid-lowering drug use for ASCVD prevention.
  • To outline risk stratification methods and recommended statin intensity.
  • To detail monitoring recommendations and alternative therapies.

Main Methods:

  • Review of guidelines from the American College of Cardiology/American Heart Association (ACC/AHA), U.K. National Institute for Health and Care Excellence (NICE), and U.S. Preventive Services Task Force (USPSTF).
  • Analysis of recommendations for statin initiation based on calculated 10-year ASCVD risk.
  • Examination of guidelines regarding monitoring of liver transaminases and lipid levels.
  • Evaluation of evidence for alternative lipid-lowering drugs and newer agents.

Main Results:

  • Statin therapy is recommended for primary prevention if 10-year ASCVD risk is ≥7.5% (ACC/AHA) or ≥10% (NICE, USPSTF).
  • Patients with established ASCVD should receive high-intensity statins, with moderate-intensity as an alternative for specific populations or intolerance.
  • Monitoring guidelines for liver enzymes and lipids vary, with rechecking lipid levels 1-3 months after initiation recommended.
  • Niacin is not recommended; ezetimibe may be beneficial with statins in certain conditions; PCSK9 inhibitors show potential but require further study.

Conclusions:

  • Risk-based statin therapy is the cornerstone of ASCVD prevention, aligning with major international guidelines.
  • Monitoring protocols for statin therapy require careful consideration of individual patient factors and guideline recommendations.
  • Alternative lipid-lowering agents and emerging therapies offer options for patients who do not meet goals or tolerate statins.